Browsing by Author Cooper, David A.
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
|---|---|---|
| 7-Dec-1995 | A short-term study of the safety pharmacokinetics and efficacy of ritonavir, an inhibitor of HIV-1 protease | Danner, Sven A.; Carr, Andrew; Leonard, John M.; Lehman, Leah M.; Gudiol i Munté, Francesc; Gonzales, Juan; Raventós, Antonio; Rubio, Rafael; Bouza, Emilio; Pintado, Vicente; Gil Aguado, Antonio; Garcia de Lomas, Juan; Delgado, Rafael; Borleffs, Jan C.C.; Hsu, Ann; Valdes, Joaquin M.; Boucher, Charles A. B.; Cooper, David A.; European-Australian Collaborative Ritonavir Study Group |
| 15-Dec-2014 | Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration | Duda, Stephany N.; Farr, Amanda M.; Lindegren, Mary Lou; Blevins, Meridith; Wester, C. William; Wools-Kaloustian, Kara; Ekouevi, Didier K.; Egger, Matthias; Hemingway-Foday, Jennifer; Cooper, David A.; Moore, Richard D.; McGowan, Catherine C.; Nash, Denis; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration |
| 2-Nov-2014 | Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection | Thornhill, John; Inshaw, Jamie; Oomeer, Soonita; Kaleebu, Pontiano; Cooper, David A.; Ramjee, Gita; Schechter, Mauro; Tambussi, Giuseppe; Fox, Julie; Miró Meda, José M.; Weber, Jonathan; Babiker, Abdel; Porter, Kholoud; Fidler, Sarah |
| 12-Sep-2014 | HIV-1 DNA predicts disease progression and post-treatment virological control | Williams, James P.; Hurst, Jacob; Stöhr, Wolfgang; Robinson, Nicola; Brown, Helen; Fisher, Martin; Kinloch, Sabine; Cooper, David A.; Schechter, Mauro; Tambussi, Giuseppe; Fidler, Sarah; Carrington, Mary; Babiker, Abdel; Weber, Jonathan; Koelsch, Kersten K.; Kelleher, Anthony D.; Phillips, Rodney E.; Frater, John; Miró Meda, José M.; Gatell, José M.; SPARTAC Trial Investigators |
| 31-Aug-2012 | Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection | Hamlyn, Elizabeth; Ewings, Fiona M.; Porter, Kholoud; Cooper, David A.; Tambussi, Giuseppe; Schechter, Mauro; Pedersen, Court; Okulicz, Jason F.; McClure, Myra; Babiker, Abdel; Weber, Jonathan; Fidler, Sarah; Miró Meda, José M.; López-Diéguez, María; Manzardo, Christian; Arnaiz Gargallo, Juan Alberto; Pumarola Suñé, Tomàs; Plana Prades, Montserrat; Tuset Creus, Montserrat; Ligero, M. C.; García, M. T.; Gallart, Teresa; Gatell, José M.; INSIGHT SMART; SPARTAC Trial Investigators |
| 29-Jul-1993 | Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter | Cooper, David A.; Gatell, José M.; Kroon, Susanne; Clumeck, Nathan; Millard, Judith; Goebel, Frank-D; Bruun, Johan N.; Stingl, Georg; Melville, Rex L.; González Lahoz, Juan María; Stevens, John W.; Fiddian, A. Paul; Gudiol i Munté, Francesc; Miró Meda, José M.; Mallolas Masferrer, Josep; European-Australian Collaborative Group |